bexom biomedical is a startup based in the United Kingdom, most recent round Pre-Seed, 1 tracked investor.
bexom biomedical is a company headquartered in the United Kingdom. Its most recent tracked round is Pre-Seed. Brouky records 1 investor associated with the company.
Bexson Biomedical is a research-stage company developing a subcutaneous ketamine treatment platform for pain management and mental health disorders. Their lead product, BB106, utilizes a wearable infusion pump for precise dosing of ketamine.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.